Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Maravai LifeSciences Holdings, Inc. (MRVI : NSDQ)
 
 • Company Description   
Maravai LifeSciences Holdings Inc. is a life sciences company providing products for the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. The company offer products and services in the fields of nucleic acid synthesis, bioprocess impurity detection and analysis, protein labeling and detection to biopharmaceutical, vaccine, diagnostics and cell and gene therapy companies. Maravai LifeSciences Holdings Inc. is based in SAN DIEGO, Calif.

Number of Employees: 470

 
 • Price / Volume Information   
Yesterday's Closing Price: $33.58 Daily Weekly Monthly
20 Day Moving Average: 1,796,101 shares
Shares Outstanding: 255.21 (millions)
Market Capitalization: $8,569.85 (millions)
Beta: 0.76
52 Week High: $63.55
52 Week Low: $23.16
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -5.65% 6.26%
12 Week 0.24% 10.19%
Year To Date -19.86% -4.91%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
10770 WATERIDGE CIRCLE SUITE 200
-
SAN DIEGO,CA 92121
USA		 ph: 858-546-0004
fax: -		 ir@maravai.com http://www.maravai.com
 
 • General Corporate Information   
Officers
Carl Hull - Chief Executive Officer
Kevin Herde - Chief Financial Officer
Anat Ashkenazi - Director
Sean Cunningham - Director
Benjamin Daverman - Director

Peer Information
Maravai LifeSciences Holdings, Inc. (BJCT)
Maravai LifeSciences Holdings, Inc. (CADMQ)
Maravai LifeSciences Holdings, Inc. (APNO)
Maravai LifeSciences Holdings, Inc. (UPDC)
Maravai LifeSciences Holdings, Inc. (IMTIQ)
Maravai LifeSciences Holdings, Inc. (CYGN)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 56600D107
SIC: 2834
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/09/22
Share - Related Items
Shares Outstanding: 255.21
Most Recent Split Date: (:1)
Beta: 0.76
Market Capitalization: $8,569.85 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.45 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $1.83 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 6.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/09/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 18.35
Trailing 12 Months: 17.96
PEG Ratio: -
Price Ratios
Price/Book: 13.10
Price/Cash Flow: 19.49
Price / Sales: 9.57
EPS Growth
vs. Year Ago Period: 107.69%
vs. Previous Quarter: 20.00%
Sales Growth
vs. Year Ago Period: 64.83%
vs. Previous Quarter: 6.94%
ROE
03/31/22 - 96.51
12/31/21 - 105.25
09/30/21 - 109.36
ROA
03/31/22 - 25.71
12/31/21 - 23.99
09/30/21 - 20.58
Current Ratio
03/31/22 - 7.14
12/31/21 - 7.89
09/30/21 - 6.01
Quick Ratio
03/31/22 - 6.55
12/31/21 - 7.34
09/30/21 - 5.52
Operating Margin
03/31/22 - 53.53
12/31/21 - 50.76
09/30/21 - 47.04
Net Margin
03/31/22 - 25.25
12/31/21 - 22.83
09/30/21 - 22.69
Pre-Tax Margin
03/31/22 - 67.96
12/31/21 - 66.41
09/30/21 - 59.99
Book Value
03/31/22 - 2.56
12/31/21 - 2.14
09/30/21 - 1.76
Inventory Turnover
03/31/22 - 2.88
12/31/21 - 2.77
09/30/21 - 2.70
Debt-to-Equity
03/31/22 - 0.80
12/31/21 - 0.96
09/30/21 - 1.28
Debt-to-Capital
03/31/22 - 44.49
12/31/21 - 49.03
09/30/21 - 56.15
 

Powered by Zacks Investment Research ©